IMPLANET Reports Revenue of €4.3 Million in the First Half of 2023

Regulatory News:

IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral implants for orthopedic surgery and the distribution of technological medical equipment, today announced its revenue for the first half of 2023.

Ludovic Lastennet, IMPLANET’s CEO, stated: “Implanet recorded stable revenue in the first half of 2023 compared with the same period of 2022, but the semester was marked by determined commercial launches resulting from our acquisition of OSD and our partnership with Sanyou Medical. Firstly, the exclusive distribution contract signed for Europe with SMTP, a subsidiary of Sanyou Medical, allows Implanet to offer a new activity distributing medical equipment to healthcare facilities. This activity, which has recorded a strong commercial performance since March, should represent a real growth engine in the coming months. At the same time, we have strengthened our presence in the United States with the FDA’s approval of our Squale^TM range of anterior cages. This range will be supplemented at the end of the year with a fixation system enabling us to provide a comprehensive range for treating cervical pathologies. Lastly, in June we initiated the European commercial launch of an innovative minimally invasive pedicle screw system. This is the first range resulting from Implanet and Sanyou Medical’s combined expertise. These various elements are fully consistent with the strategy we have been deploying over the last two years or so aimed at establishing Implanet as a key player in spine surgery. We intend to build on this momentum over the coming months, the culmination being the upcoming initiation of Sanyou Medical’s distribution of our JAZZ range in China, the world’s largest spine market by volume, with the first surgeries expected before the end of the year”.

Financial information for the first half of 2023

Revenue (in € thousands - IFRS*)		H1 2023	H1 2022	Change
Spine	France	1,788	1,801	-1%
	United States	818	802	+2%